# AbbVie Inc (ABBV)

AbbVie is facing scrutiny over Botox pricing controls as it sues a US health agency, while also advancing its upadacitinib drug for vitiligo.

### About AbbVie Inc
AbbVie Inc. is a global biopharmaceutical company.  
AbbVie Inc uses the ticker $ABBV for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- AbbVie Inc (ABBV) social dominance is up 42.15% from the previous week.

### Price: $231.50
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$abbv/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$abbv/time-series/close.tsv)  
AbbVie's stock is trading near a 52-week low due to concerns over drug trial failures and potential overvaluation, despite positive social media sentiment and news of dividend increases and pipeline expansions.  

24-Hour: 1.76%
7-Day: 3.06%
30-Day: 8%

1-Year High: $244.40 on 2025-10-01  
1-Year Low: $170.20 on 2025-04-21  
  
  
### AltRank: [---]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$abbv/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$abbv/time-series/alt_rank.tsv)  
AbbVie Inc (ABBV) is currently AltRank #542 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [---] +505  
[--] Month: [---] +46  
[--] Months: [---] [---]  
[--] Year: [---] +352  
1-Year High: [-----] on 2026-01-26  
1-Year Low: [--] on 2025-07-05  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$abbv/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$abbv/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] +2  
[--] Month: [--] +9  
[--] Months: [--] [---]  
[--] Year: [--] +16  
1-Year High: [--] on 2025-05-12  
1-Year Low: [--] on 2025-02-26  
  
  
### Engagements: [-------] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$abbv/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$abbv/time-series/interactions.tsv)  
Current Value: [-------]  
Daily Average: [-------]  
[--] Week: [---------] -27%  
[--] Month: [---------] +4.40%  
[--] Months: [----------] -34%  
[--] Year: [----------] -24%  
1-Year High: [---------] on 2025-05-07  
1-Year Low: [------] on 2025-09-14  

Engagements by network (24h):
Reddit: [---]
Instagram: [---]
News: [--]
YouTube: [------]
TikTok: [-----]
X: [------]

  
  
### Mentions: [-----] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$abbv/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$abbv/time-series/posts_active.tsv)  
Current Value: [-----]  
Daily Average: [---]  
[--] Week: [-----] -23%  
[--] Month: [-----] +67%  
[--] Months: [------] -53%  
[--] Year: [------] +14%  
1-Year High: [-----] on 2025-07-03  
1-Year Low: [---] on 2026-01-01  

Mentions by network (24h):
Reddit: [--]
Instagram: [--]
News: [--]
YouTube: [--]
TikTok: [--]
X: [---]

  
  
### Creators: [---] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$abbv/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$abbv/time-series/contributors_active.tsv)  
[---] unique social accounts have posts mentioning AbbVie Inc (ABBV) in the last [--] hours which is down 5.50% from [---] in the previous [--] hours
Daily Average: [---]  
[--] Week: [-----] -21%  
[--] Month: [-----] +52%  
[--] Months: [------] -57%  
[--] Year: [------] +175%  
1-Year High: [-----] on 2025-07-03  
1-Year Low: [---] on 2026-01-01  

The most influential creators that mention AbbVie Inc in the last [--] hours

| Creator                                              | Rank | Followers  | Posts | Engagements |
| -------                                              | ---- | ---------  | ----- | ----------- |
| [@aktiechaffisen](/creator/twitter/aktiechaffisen)   | [--]    | [-----]      | [--]     | [------]      |
| [@upediashorts](/creator/youtube/upediashorts)       | [--]    | [----------] | [--]    | [------]      |
| [@bugra_kurtoglu](/creator/twitter/bugra_kurtoglu)   | [--]    | [-------]    | [--]     | [-----]       |
| [@investwithsheng](/creator/twitter/investwithsheng) | [--]    | [------]     | [--]     | [-----]       |
| [@HOThomasWPhelps](/creator/twitter/HOThomasWPhelps) | [--]    | [-----]      | [--]     | [-----]       |
| [@Dividend_Dollar](/creator/twitter/Dividend_Dollar) | [--]    | [-------]    | [--]     | [---]         |
| [@abbvie](/creator/tiktok/abbvie)                    | [--]    | [-----]      | [--]    | [---]         |
| [@bullrunalpha](/creator/twitter/bullrunalpha)       | [--]    | [---]        | [--]     | [---]         |
| [@stevenplace](/creator/twitter/stevenplace)         | [--]    | [-----]      | [--]     | [---]         |
| [@NitranTrades](/creator/twitter/NitranTrades)       | [--]   | [---]        | [--]     | [---]         |

[View More](/list/creators/$abbv/100)
  
  
### Sentiment: 86%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$abbv/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$abbv/time-series/sentiment.tsv)  
Current Value: 86%  
Daily Average: 84%  
[--] Week: 84% -7%  
[--] Month: 81% -1%  
[--] Months: 81% no change  
[--] Year: 81% -8%  
1-Year High: 98% on 2025-07-04  
1-Year Low: 66% on 2025-06-17  

Most Supportive Themes:
- Product and Pipeline Updates: (35%) AbbVie's advancements in drug development and clinical trials, including positive results for upadacitinib and strategic acquisitions.
- Dividend and Value: (25%) AbbVie's status as a strong dividend-paying stock, attracting investors focused on income and value.
- Positive Sentiment and All-Time Highs: (15%) Strong investor confidence and positive market sentiment surrounding AbbVie's stock performance.
  
Most Critical Themes:
- Overvaluation Concerns: (10%) Analyses suggesting that AbbVie's stock may be overvalued, potentially leading to a future price correction.
- Competition and Market Dynamics: (5%) Competitive pressures from other pharmaceutical companies and discussions about market dominance.
  
  
  
### Social Dominance: 0.065%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$abbv/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$abbv/time-series/social_dominance.tsv)  
Current Value: 0.065%  
Daily Average: 0.14%  
[--] Week: 0.065% +0.019%  
[--] Month: 0.10% -0.021%  
[--] Months: 0.10% -0.051%  
[--] Year: 0.10% -0.126%  
1-Year High: 0.585% on 2025-07-04  
1-Year Low: 0.048% on 2025-12-02  
  
  
### Market Dominance: 0.463%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$abbv/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$abbv/time-series/market_dominance.tsv)  
Current Value: 0.463%  
Daily Average: 11%  
1-Year High: 18.20% on 2026-02-06  
1-Year Low: 0.463% on 2026-02-14  
  
  
### Market Cap: $409,149,542,308
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$abbv/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$abbv/time-series/market_cap.tsv)  
Current Value: $409,149,542,308  
Daily Average: $367,338,298,519  
[--] Week: $410,421,705,766 +4.60%  
[--] Month: $409,149,542,308 +6.80%  
[--] Months: $409,149,542,308 +12%  
[--] Year: $409,149,542,308 +20%  
1-Year High: $431,711,505,868 on 2025-10-01  
1-Year Low: $300,571,139,074 on 2025-04-21  

### Top AbbVie Inc Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"My Dividend Portfolio vs the SP500: [--] Year Results In this video Im going to show you my dividend portfolio which just hit a brand-new all-time high and I'll break down my total returns over the last five years I've been at Fidelity comparing them to the S&P [---] and to the total US stock market. Ill also share some insights from doing my [----] taxes that you might be interested to see especially if youre looking for ways to keep more of those dividends in your pocket. Use my FAST Graphs Link and coupon code AFFILIATE25 to get 25% off your 1st payment for new signups ➡"  
[YouTube Link](https://youtube.com/watch?v=fRrSwYUApwo) [@genexdividendinvestor](/creator/youtube/genexdividendinvestor) 2026-02-14T14:00Z 84.7K followers, [----] engagements


"Breaking News: $ABBV [--] Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off News & Disclaimer @grok please provide the finance card for $ABBV https://marketwirenews.com/news-releases/2-unstoppable-dividend-stocks-to-buy-if-there-s-a-st-8413234653832175.html https://marketwirenews.com/news-releases/2-unstoppable-dividend-stocks-to-buy-if-there-s-a-st-8413234653832175.html"  
[X Link](https://x.com/marketwirenews/status/2022669677055422951) [@marketwirenews](/creator/x/marketwirenews) 2026-02-14T13:50Z 60.6K followers, [---] engagements


"mr boyu dzenli gelir elde edebileceiniz ABD borsasnn dev temett irketleri: 🎗 Coca Cola $KO 🎗 Johnson & Johnson $JNJ 🎗 Lockheed Martin $LMT 🎗 Altira $MO 🎗 Visa $V 🎗 Microsoft $MSFT 🎗 Pepsi $PEP 🎗 Home Depot $HD 🎗 JP Morgan $JPM 🎗 Mc Donald's $MCD 🎗 Exxon Mobil $XOM 🎗 Abbvie $ABBV Bu irketler sadece bugn deil gelecek on yllarda da istikrarl nakit ak sunmaya devam edecek kkl devlerdir. https://twitter.com/i/web/status/2022641976487956720 https://twitter.com/i/web/status/2022641976487956720"  
[X Link](https://x.com/anyuser/status/2022641976487956720) [@undefined](/creator/x/undefined) 2026-02-14T12:00Z 16.8K followers, [----] engagements


"Mein Healthcare-Sektor im Dividendendepot Ich habe mich im Sektor Gesundheit fr folgende drei Unternehmen entschieden: Johnson & Johnson $JNJ Abbvie $ABBV Zoetis $ZTS Johnson & Johnson Gewinnt bei Scale + Prozess + regulatorischer Macht Extrem breit und stabil Institutionelle Dominanz 👉 Strukturell am massivsten abgesichert Div 214% 5Y CAGR 513% AbbVie Gewinnt bei Switching Costs Sehr starke Produktmacht Hhere Abhngigkeit von Therapiebereichen 👉 Hchste Cashflow-Hebelwirkung aber weniger Diversifikation Div 287% 5Y CAGR 62% Zoetis Gewinnt bei Brand + Fokus + Counter-Positioning Extrem"  
[X Link](https://x.com/Dividend_Flow/status/2022581588110844221) [@Dividend_Flow](/creator/x/Dividend_Flow) 2026-02-14T08:00Z [---] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing